Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Healius Limited (HLS.AX)

Compare
1.4000
-0.0400
(-2.78%)
At close: April 11 at 4:10:17 PM GMT+10

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Mr. Paul D. Anderson B.Com., C.A. MD, CEO & Director 926.55k -- --
Mr. Stephen Humphries B.Sc. CFO& Company Secretary 684.07k -- --
Dr. Jan Van Rooyen Head & Group Executive of Healius Pathology 1.43M -- --
Ms. Paula Bayliss Group Executive of People & Culture -- -- --
Mr. John McKechnie Advisor 898.22k 855.47k --
Dr. Phil Lucas Chief Executive of Lumus Imaging -- -- --
Ian Mcphan Chief Operating Officer of Healius Pathology -- -- --
Sharon Ng Head of Group FP&A -- -- --
Mr. Jon Eide Group Executive of Commercial & Customer -- -- --
Alejandro Rosales Head of Digital Strategy & Delivery Office -- -- --

Healius Limited

161 Castlereagh Street
Level 22
Sydney, NSW 2000
Australia
61 2 9432 9400 https://www.healius.com.au
Sector: 
Healthcare
Full Time Employees: 
4,329

Description

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Corporate Governance

Healius Limited’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 9; Board: 3; Shareholder Rights: 7; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 19, 2025 at 10:11 PM UTC

Healius Limited Earnings Date

Recent Events

September 7, 2022 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers